Skip to main content

Table 6 Outcome in relation to sites of metastatic disease

From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

Site of Metastasis # of Patients Median Survival (mo.) p – value
Lung    
   No 64 13.1 .0474
   Yes 31 11.9  
Liver    
   No 24 14.7 .5114
   Yes 71 12.7  
1 Intra-abdominal    
   No 59 17.1 .0043*
   Yes 36 9.3  
Lymph Nodes    
   No 85 13.2 .3319
   Yes 10 12.5  
# of Metastasis    
   1 49 17.1 .0009*
   2 35 10.9  
   3 11 6.5  
  1. 1Intra-abdominal metastasis refers to disease involving the colon, rectum, pancreas, abdominal wall, bladder, prostate, pelvis or adrenals.